News/Events

Catalent Completes Tender Offer for All Outstanding Shares of Juniper Pharmaceuticals, Inc.

2 months ago

Nottingham, U.K.-based dose form development and clinical manufacturing specialist, Juniper will add a European Early Development Center of Excellence to Catalent’s global network. When combined with Catalent’s existing centers of excellence for early drug development in the U.S. and Europe, the acquisition of Juniper will expand and strengthen Catalent’s offerings and will complement its integrated

Juniper Pharma Services continues its strategic capital investment in oral solid dose services

4 months ago

Nottingham, UK – Juniper Pharma Services (JPS), a Contract Development and Manufacturing Organisation (CDMO) specialising in the development of challenging small molecules, is continuing its strategic investment in oral solid dose manufacturing with a $1.7m purchase of three additional pieces of processing equipment. This investment enhances JPS’ commitment to rapidly transform promising molecules into successful

Juniper Pharma Services expands laboratory facilities to meet with growing demand

4 months ago

Nottingham, UK – Juniper Pharma Services (JPS), a Contract Development and Manufacturing Organisation (CDMO) specialising in the development of challenging small molecules, has announced a significant expansion to its UK-based drug development and clinical trial manufacturing facilities. The extension provides four additional process development laboratories at its Nottingham site, improving the output and efficiency of

Juniper Pharma Services to Participate in Inaugural West Coast Advancing Drug Development Forum

4 months ago

Nottingham, UK – Juniper Pharma Services (JPS), a Contract Development and Manufacturing organisation (CDMO) specialising in the development of challenging small molecules, will be attending the 2nd ‘Advancing Drug Development Forum (ADDF) – Making the Impossible, Possible.’ on June 14th at the San Francisco Wine School, California. JPS will be joining key opinion leaders at

Juniper Pharma Services’ co-founder awarded CBE in the Queen’s New Year’s Honours List

10 months ago

Juniper Pharmaceuticals (Nasdaq:JNP), a diversified healthcare company focused on women’s health, today announced that Juniper Pharma Services co-founder Martyn Davies, PhD, has been appointed as a Commander of the Order of the British Empire (CBE) in Her Majesty’s 2018 New Year’s Honours List. The honours system recognises people who have made achievements in public life

Juniper Pharma Services and XenoGesis strengthen alliance in early drug development services

1 year ago

Nottingham, UK – Juniper Pharma Services and XenoGesis have extended their strategic alliance around their Enabling Technologies Rapid Screen through the addition of the gold standard PBPK modelling and simulation software, GastroPlusTM. This expanded partnership brings greater understanding of a compound’s potential exposure in both preclinical and clinical studies. Jointly they are already working in

Major Progress in Next Generation Medicines Initiative

1 year ago

Nottingham, UK – Juniper Pharma Services, a subsidiary of Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), has reached a key milestone in its work with CrystecPharma and the Advanced Manufacturing Supply Chain Initiative (AMSCI) to create a new platform to accelerate drug development. The contract development and manufacturing organisation (CDMO) now has CrystecPharma’s supercritical fluid technology platform

Webinar – The Importance of Dose Prediction for Early Drug Development

1 year ago

Juniper Pharma Services will be presenting a webinar with Xenogesis: The Importance of Dose Prediction for Early Drug Development at 3.00pm (BST) on Thursday 6th July 2017. The webinar will examine how gaining a thorough understanding of the chemical and pharmacological attributes of a drug substance through preclinical studies is paramount for providing an effective dosage form

Juniper Pharma Services Brings PSD-1 Spray Dryer Online

1 year ago

Nottingham, UK – Juniper Pharma Services (“the company” or “Juniper”), a subsidiary of Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), has broadened its manufacturing capabilities bringing on-line its new spray dryer following the successful installation and validation of the advanced manufacturing equipment at its UK-based site. The contract development and manufacturing organisation (CDMO) has seen significant interest

Juniper Pharma Services expands granulation capabilities

2 years ago

Nottingham, UK – Juniper Pharma Services (“the company”), a subsidiary of Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), has added a roller compactor to its enabling technologies platform to satisfy increasing market demand for its pharmaceutical development services. The UK-based contract development and manufacturing organisation (CDMO) has purchased a Gerteis MINI-PACTOR® to expand its granulation capabilities and